This no-implant atrial shunt could offer an effective treatment for heart failure. [Image courtesy of Alleviant Medical] Alleviant Medical announced today that it raised $90 million to fund the ...

Disappearance of atrial left-to-right shunting was demonstrated by cardiac catheterization and cineangiography between seven days and fifteen months (Case 1), three weeks and eight months (Case 2 ...

The US Food and Drug Administration (FDA) has granted Alleviant Medical an investigational device exemption (IDE), enabling the company to begin a pivotal trial evaluating its atrial shunt ...

Atrial fibrillation (AFib) can affect life expectancy due to factors that include age, underlying health conditions, race, and how this common cardiac arrhythmia—or abnormal heart rhythm— is treated.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...